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~ L o f t  Ventrlcuinr Dilatation Is Associated With 
Increased Risk of Congcstlve Heart Fallum: The 
Framinghsm Heart Study 
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National Heart Lung and Blood Institute, Bethesd& MD 
We examined the relations of M.mode echocardiographic LV encl-diesinlic 
(LVI0~) and LV end-systolic (LVIDe~) dimensions to dsk of congestive heart 
failure {CHF) In 4905 subjects (2202 men, 2703 women; 148 with prior MI) 
who were froe of CHFand who had echocardiography ataroutine xam. LVID 
was graded as 0 (no dilatation) to 4 (severe dgata~) based on increasing 
deviation from height- and sex-specific 95 th percentile values of LVID in a 
healthy reference sample. Cox proportional hazards regression (stratified 
by sex and prior MI status) was used to assess differences in time tO CHF 
among LVID categodas after adjusting for age, blood pressure, hype~ension 
treatment, diabetes and valve disease. Separate analyses were pedormed 
for LVIDea and LVID~. Over an 8-year period, 95 sul~ects (52 men, 43 
women; 75 w/thout prior MI) developed CHF. Risk of CHF increased across 
categories of LVID in both sexes, independent of pdor MI status and LV wall 
thickness. 
LVID categoP/ Trend test 
0 1 2 3 4, - pvakm 
R~k factor-adjusfadhazardr~/o 
LVIDed 1,0 1.72 2,98 5.13 8.85 .~ 0.0001 
LVlDes 1,0 1,66 2.75 4.56 7.56 < 0.0001 
Conclusions: Echocardiogmphic measures of LV diameter can iderCdfy 
subjects who are at increased dsk for CHR Knowledge of LVID improves 
the prediction of risk of CHF made from traditional dsk faclors, perhaps by 
iderttifying subjects with subclinical LV dysfunction. 
~ A r o  Meta Analysis Methods Valid ~ Reverse Meta 
Analysis 
Sebest~n 1". Palmed, Jofm 13. Kostis~ Ron Cody, Alan C. ~lson. Daniel 
M. Shindler, William Strawderman. UMDNJ-Robert Wood Johnson Medical 
School; Rutgers University, New Brunswick, NJ 
The need for timely yet less costly sdentiti¢ clinical information has led 
to the wider use of composite end point trials and meta ana~is. To test 
the validity of these methods, we divided the S'mdles of Left Ventdcular 
Dysfunction (SOLVD) Prevention Trial into randomly ~ blocks, then 
conducted a meta analysis on the 2 Outcome measures repeat~ 500 times. 
We then rosampled the original population to recreate possible confounding 
factors such as entry cdteda differences [left vectricular ejection fra~on 
(El=)]. Publication bias (Pub bias) was demonstrated by selecting only ralx~m 
blocks with p values < 0.10. Reconstruction by reveres meta analysis (Rev 
Meta) yielded results identical to the odgi~al SOLVD findings. Pub bias 
converted an insignificant mortality rasuit into a highly significant outcome. 
Death D,~th or CHF 
Odds~ P Odds. Ratio P 
SOLVD %038 0,391 1.12'3 0,002 
Rev Meta t.038 0.394 1.123 0.002 
Pub Bias 2.517 0.001 t.395 0.001 
EF > 30% 0.992 0,913 0,999 0,986 
EF 20-80% 1.05 0.42 1.178 0,002 
EF < 20% 1.15 0.31 1.351 0,018 
We observed that meta analysis methods accurately reconstructed a frag- 
mented single protocol clinical trial. However, when selective sampling tech- 
niquas were used to simulate d'~erent inclusion criteria and publication bias, 
the study conclusions were signiflcantiy altered, Thus, results of meta anal- 
ysts should be accepted with caution in dinical decision making or the 
formulation of pmcllce guidelines. 
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Despite potential adverse effects of atrial fibrillation (AF) in heart failure (HF), 
studies of mortality are conflicting. The impact of AF on survival as therapy 
for HF has evolved was assessed for 750 conseculive advanced HF patients 
(LV ejection fraction 0.21 :E 0.07). From 1985-89 (Group 1) hydr~azine 
and Class I anttaldlythmics were routinely allowed. From 19g0-93 (Group 
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II) amiedarone (Amio) was the preferred antianhythmic and angietensin 
converling enzyme inhibitors (ACE-i) were first choice vasodilators. 
Results: Drug therapy changed over time (Table). Group I vs. Group II AF 
patients had similar hemodynamic profiles, but 2-year survival was better for 
group II AF patients (p = 0.001). In group I, AF patients had worse survival 
(at~clute ddferense 16%) compared to patients without AF (p = 0.002). In 
group I! the mortality d'~eronce of 9% for AF vs. no AF patients did not roach 
significance (p : 0.09). 
Group I Group, p 
AF NoN= AF NON= 
N 73 286 93 298 
Czsss 1% 33 29 10 7 < 0.0001 
Amto % 30 14 71 49 < O.QO01 
ACE-1% 39 48 7'6 80 < 0,0001 
2-Year ~ lva l  0.98 0.S5 0.66 0.75 
CondO:  With current management of advanced heart faJturo, AF no 
longer has a major impact on Fog.osis. 
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~ Relative Coronary Row and Collateral Circulation 
_as ~ by Tc-99m Sestamibi Scintigraphy 
ro l lo~ng Selective Right Coronary Artery 
Injection 
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In order to determine the regional blood flow patterns of the right coronary 
artery, an intmcomnary injection of Tc-99m sestamibt (S) was administered 
to pts with (n = 5) and without (n = 15) angiographic (A) collaterals (C). S 
activily was quantilated as mean counts per pixel in 8 large regions On three 
sepamto short axis slices. Each ~gion was then averaged and exlxessed 
as percentage Of poak activity. There was algnircan~ gTeater S activity in 
the septal (p < 0.0001), ante~ (p < 0,003) and inferoseptal (p < 0.03) 
regions in pts with C as compared to those without C. The graph bek~w 
represents the percent of peak activity (~ 2 SD) in each region besed On the 
presence or absence of C S activity was fired con'elated with AC; evalustion 
of sclntigraphic C was blinded to the ang i0g~ findings. S d~sto~e,~on 
correlated with AC in 30/30 region~ within ~ LAD tentto~. Them were 
no ptS with AC without sdnt ig~ demonstmJion Of C. Alternatively, no S 
activity was present within the LAD without AC. Thus, S acti~y precisely 
correlated with the A distnl0ution of the RCA. 
o:senrations indcato that the extent and distn'l~Jtion of C may be 
assessed by ~ctracomcary injection of S with tbe potential edded advantage 
of quantitation Of relative bloed flow. 
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Redused myocardial btood tiow (MBF) has been proposed as a mechanism 
for myocardial h ibe~ in patients ~ chronic ¢oronmy adefy disease 
(CAD). These patients may exhibit a positive inohepic response to dobu- 
tamine (DUb) which, in turn, me/predct recover/of Seft ventr~u~ (LV) 
function after revascuisrizatinn. However, whether the instmpin reserve is 
related to MBF in these patients has not been as~b~ished. To this end, we 
